Seattle Genetics Share Holder Equity 2006-2019 | SGEN

Seattle Genetics share holder equity from 2006 to 2019. Share holder equity can be defined as the sum of preferred and common equity items
  • Seattle Genetics share holder equity for the quarter ending June 30, 2019 was $1.272B, a 8% decline year-over-year.
  • Seattle Genetics share holder equity for 2018 was $1.274B, a 88.02% increase from 2017.
  • Seattle Genetics share holder equity for 2017 was $0.678B, a 6.86% increase from 2016.
  • Seattle Genetics share holder equity for 2016 was $0.634B, a 7.56% decline from 2015.
Seattle Genetics Annual Share Holder Equity
(Millions of US $)
2018 $1,274
2017 $678
2016 $634
2015 $686
2014 $211
2013 $230
2012 $226
2011 $219
2010 $162
2009 $206
2008 $79
2007 $54
2006 $88
2005 $75
Seattle Genetics Quarterly Share Holder Equity
(Millions of US $)
Q2 2019 $1,272
Q1 2019 $1,313
Q4 2018 $1,274
Q3 2018 $1,365
Q2 2018 $1,382
Q1 2018 $1,279
Q4 2017 $678
Q3 2017 $660
Q2 2017 $574
Q1 2017 $603
Q4 2016 $634
Q3 2016 $662
Q2 2016 $669
Q1 2016 $684
Q4 2015 $686
Q3 2015 $696
Q2 2015 $180
Q1 2015 $209
Q4 2014 $211
Q3 2014 $225
Q2 2014 $226
Q1 2014 $231
Q4 2013 $230
Q3 2013 $234
Q2 2013 $237
Q1 2013 $233
Q4 2012 $226
Q3 2012 $223
Q2 2012 $219
Q1 2012 $220
Q4 2011 $219
Q3 2011 $231
Q2 2011 $264
Q1 2011 $305
Q4 2010 $162
Q3 2010 $190
Q2 2010 $219
Q1 2010 $222
Q4 2009 $206
Q3 2009 $216
Q2 2009 $100
Q1 2009 $107
Q4 2008 $79
Q3 2008 $106
Q2 2008 $124
Q1 2008 $138
Q4 2007 $54
Q3 2007 $65
Q2 2007 $74
Q1 2007 $82
Q4 2006 $88
Q3 2006 $97
Q2 2006 $104
Q1 2006 $68
Q4 2005 $75
Q3 2005 $83
Q2 2005 $89
Q1 2005 $97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.422B $0.655B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.224B 13.35
Gilead Sciences (GILD) United States $84.245B 10.35
CSL (CSLLY) Australia $72.048B 0.00
Celgene (CELG) United States $69.740B 10.79
Vertex Pharmaceuticals (VRTX) United States $44.966B 48.59
Illumina (ILMN) United States $44.234B 51.97
Biogen (BIIB) United States $43.646B 7.75
Regeneron Pharmaceuticals (REGN) United States $30.931B 14.04
Alexion Pharmaceuticals (ALXN) United States $24.082B 12.69
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.438B 48.37
Exact Sciences (EXAS) United States $13.817B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.038B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.307B 0.00
Galapagos (GLPG) Belgium $8.835B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.614B 52.60
Guardant Health (GH) United States $7.205B 0.00
Sarepta Therapeutics (SRPT) United States $6.393B 0.00
BeiGene (BGNE) Cayman Islands $6.372B 0.00
Amarin (AMRN) Ireland $5.969B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.845B 0.00
Exelixis (EXEL) United States $5.828B 15.15
Bluebird Bio (BLUE) United States $5.795B 0.00
Moderna (MRNA) United States $5.517B 0.00
Horizon Pharma Public (HZNP) Ireland $4.911B 12.48
ARGENX SE-ADR (ARGX) Netherlands $4.760B 0.00
Ascendis Pharma (ASND) Denmark $4.370B 0.00
Repligen (RGEN) United States $4.109B 79.74
Spark Therapeutics (ONCE) United States $4.032B 0.00
China Biologic Products (CBPO) China $3.914B 24.43
Blueprint Medicines (BPMC) United States $3.877B 0.00
Medicines (MDCO) United States $3.790B 0.00
MorphoSys AG (MOR) Germany $3.725B 0.00
Alkermes (ALKS) Ireland $3.504B 0.00
Mirati Therapeutics (MRTX) United States $3.362B 0.00
Immunomedics (IMMU) United States $3.210B 0.00
Emergent Biosolutions (EBS) United States $2.683B 40.31
Genomic Health (GHDX) United States $2.674B 50.15
Reata Pharmaceuticals (RETA) United States $2.607B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.606B 0.00
Arena Pharmaceuticals (ARNA) United States $2.552B 5.48
Ultragenyx Pharmaceutical (RARE) United States $2.544B 0.00
Amicus Therapeutics (FOLD) United States $2.495B 0.00
MyoKardia (MYOK) United States $2.489B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Acceleron Pharma (XLRN) United States $2.313B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.253B 0.00
NeoGenomics (NEO) United States $2.218B 118.67
Myriad Genetics (MYGN) United States $2.025B 21.26
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.973B 0.00
Akcea Therapeutics (AKCA) United States $1.949B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.893B 0.00
Ligand Pharmaceuticals (LGND) United States $1.852B 23.42
Denali Therapeutics (DNLI) United States $1.804B 0.00
UniQure (QURE) Netherlands $1.797B 0.00
Insmed (INSM) United States $1.679B 0.00
Coherus BioSciences (CHRS) United States $1.409B 0.00
REGENXBIO (RGNX) United States $1.396B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.358B 0.00
Alector (ALEC) United States $1.307B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.291B 0.00
Editas Medicine (EDIT) United States $1.263B 0.00
Sangamo Therapeutics (SGMO) United States $1.255B 0.00
RA PHARMCTL INC (RARX) United States $1.208B 0.00
AnaptysBio (ANAB) United States $1.193B 0.00
Fate Therapeutics (FATE) United States $1.172B 0.00
Innoviva (INVA) United States $1.160B 3.35
Epizyme (EPZM) United States $1.089B 0.00
Athenex (ATNX) United States $1.065B 0.00
Zymeworks (ZYME) Canada $1.006B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.999B 0.00
Twist Bioscience (TWST) United States $0.973B 0.00
Cara Therapeutics (CARA) United States $0.933B 0.00
ANI Pharmaceuticals (ANIP) United States $0.926B 15.46
Arvinas (ARVN) United States $0.850B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.841B 0.00
Codexis (CDXS) United States $0.838B 0.00
Principia Biopharma (PRNB) United States $0.834B 435.13
WAVE Life Sciences (WVE) Singapore $0.821B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.769B 0.00
Anika Therapeutics (ANIK) United States $0.743B 26.30
Zealand Pharma (ZEAL) Denmark $0.742B 8.60
Cytokineticsorporated (CYTK) United States $0.727B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.724B 26.14
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Intellia Therapeutics (NTLA) United States $0.696B 0.00
Mesoblast (MESO) Australia $0.681B 0.00
DBV Technologies S.A (DBVT) France $0.618B 0.00
MiMedx (MDXG) United States $0.590B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.549B 0.00
Intra-Cellular Therapies (ITCI) United States $0.548B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.542B 0.00
Cellectis S.A (CLLS) France $0.538B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Retrophin (RTRX) United States $0.523B 0.00
Heska (HSKA) United States $0.523B 67.70
Precision BioSciences (DTIL) United States $0.496B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Stemline Therapeutics (STML) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.448B 0.00
Puma Biotechnology (PBYI) United States $0.440B 0.00
Arcus Biosciences (RCUS) United States $0.432B 0.00
BioDelivery Sciences (BDSI) United States $0.431B 0.00
Agenus (AGEN) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.410B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
Adverum Biotechnologies (ADVM) United States $0.373B 0.00
Scholar Rock Holding (SRRK) United States $0.366B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
AC Immune SA (ACIU) Switzerland $0.341B 25.25
Prothena (PRTA) Ireland $0.336B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Albireo Pharma (ALBO) United States $0.317B 0.00
Avid Bioservices (CDMO) United States $0.315B 0.00
Kindred Biosciences (KIN) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.311B 464.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
ADMA Biologics Inc (ADMA) United States $0.303B 0.00
Geron (GERN) United States $0.300B 0.00
Clovis Oncology (CLVS) United States $0.296B 0.00
Prometic Life Sciences (PFSCF) Canada $0.291B 0.00
Dynavax Technologies (DVAX) United States $0.291B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.265B 0.00
MannKind (MNKD) United States $0.260B 0.00
Inovio Pharmaceuticals (INO) United States $0.256B 0.00
PDL BioPharma (PDLI) United States $0.256B 6.59
Senesco Technologies (ELOX) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
Sutro Biopharma (STRO) United States $0.252B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.249B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.246B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.238B 0.00
Athersys (ATHX) United States $0.229B 0.00
Spero Therapeutics (SPRO) United States $0.223B 0.00
Compugen (CGEN) Israel $0.217B 0.00
Kamada (KMDA) Israel $0.212B 8.09
Five Prime Therapeutics (FPRX) United States $0.210B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Cue Biopharma (CUE) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.198B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.190B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.187B 0.00
Arsanis (XFOR) United States $0.186B 0.00
Acorda Therapeutics (ACOR) United States $0.186B 0.00
Enzo Biochem (ENZ) United States $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.173B 0.00
Emmaus Life Sciences (EMMA) United States $0.169B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
XOMA (XOMA) United States $0.164B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Northwest Biotherapeutics (NWBO) United States $0.156B 0.00
Strongbridge Biopharma (SBBP) United States $0.155B 6.36
PHASEBIO PHARMA (PHAS) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Novavax (NVAX) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Dyadic (DYAI) United States $0.150B 0.00
Abeona Therapeutics (ABEO) United States $0.146B 0.00
Adocia (ADOCY) France $0.140B 0.00
Aptinyx (APTX) United States $0.135B 0.00
NantKwest (NK) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.127B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.108B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Aduro Biotech (ADRO) United States $0.103B 0.00
Verastem (VSTM) United States $0.099B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Arbutus Biopharma (ABUS) Canada $0.095B 0.00
Idera Pharmaceuticals (IDRA) United States $0.091B 0.00
Mersana Therapeutics (MRSN) United States $0.089B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Trevena (TRVN) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Selecta Biosciences (SELB) United States $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Catalyst Biosciences (CBIO) United States $0.078B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
VBI Vaccines (VBIV) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Applied Genetic Technologies (AGTC) United States $0.067B 36.80
AquaBounty Technologies (AQB) United States $0.065B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00